Journal of Inherited Metabolic Disease

, Volume 30, Issue 2, pp 248–255 | Cite as

Xanthurenic aciduria due to a mutation in KYNU encoding kynureninase

  • M. Christensen
  • M. Duno
  • A. M. Lund
  • F. Skovby
  • E. Christensen
Original Article

Abstract

Massive urinary excretion of xanthurenic acid, 3-hydroxykynurenine and kynurenine, known as xanthurenic aciduria or hydroxykynureninuria, in a young Somali boy suggested kynureninase deficiency. Mutation analysis of KYNU encoding kynureninase of the index case revealed homozygosity for a c.593 A > G substitution leading to a threonine-to-alanine (T198A) shift. A younger brother was found to have a similar excretion pattern and the same genotype. At present, neither of the two boys has symptoms of niacin deficiency. This is the first report linking xanthurenic aciduria to a mutation in the gene encoding kynureninase.

Abbreviations

3-OHAA

3-hydroxyanthranilic acid

3-OHKYN

3-hydroxykynurenine

AA

anthranilic acid

IS

internal standard

KYN

kynurenine

KYNA

kynurenic acid

XA

xanthurenic acid

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alberati-Giani D, Buchli R, Malherbe P, et al (1996) Isolation and expression of a cDNA clone encoding human kynureninase. Eur J Biochem 239: 460–468.PubMedCrossRefGoogle Scholar
  2. Allegri G, Costa CVL, Bertazzo A, Biasiolo M, Ragazzi E (2003) Enzyme activities of tryptophan metabolism along the kynurenine pathway in various species of animals. Farmaco 58: 829–836.PubMedCrossRefGoogle Scholar
  3. Andersen NL, Fagt S, Groth MV, et al (1996) Danish Dietary Habits 1995 (English summary). National Food Authority, Report no. 235, Copenhagen: Quickly Tryk A/S: 122–123.Google Scholar
  4. Baron DN, Dent CE, Harris H, Hart EW, Jepson JB (1956) Hereditary pellagra-like skin rash with temporary cerebellar ataxia, constant renal amino-aciduria, and other bizarre biochemical features. Lancet 268: 421–428.CrossRefGoogle Scholar
  5. Bender DA (1982) Biochemistry of tryptophan in health and disease. Mol Aspects Med 6: 101–197.CrossRefGoogle Scholar
  6. Bertazzo A, Ragazzi E, Biasiolo M, Costa CVL, Allegri G (2001) Enzyme activities involved in tryptophan metabolism along the kynurenine pathway in rabbits. Biochim Biophys Acta 1527: 167–175.PubMedGoogle Scholar
  7. Christensen E, Jacobsen BB, Gregersen N, et al (1981) Urinary excretion of succinylacetone and δ-aminolevulinic acid in patients with hereditary tyrosinemia. Clin Chim Acta 116: 331–341.PubMedCrossRefGoogle Scholar
  8. Clayton PT, Bridges NA, Atherton DJ, Milla PJ, Malone M, Bender DA (1991) Pellagra with colitis due to a defect in tryptophan metabolism. Eur J Pediatr 150: 498–502.PubMedCrossRefGoogle Scholar
  9. Fridovich-Keil JL, Quimby BB, Wells L, Mazur LA, Elsevier PJ (1995) Characterization of the N314D allele of human galactose-1-phosphate uridyltransferase using a yeast expression system. Biochem Mol Med 56: 121–130.PubMedCrossRefGoogle Scholar
  10. Hegyi J, Schwartz RA, Hegyi V (2004) Pellagra: dermatitis, dementia, and diarrhea. Int J Dermatol 43: 1–5.PubMedCrossRefGoogle Scholar
  11. Horwitt MK, Harvey CC, Rothwell WS, Cutler JL, Haffron D (1956) Tryptophan-niacin relationships in man. J Nutr 60(Suppl. 1): 1–43.Google Scholar
  12. Horwitt MK, Harper AE, Henderson LM (1981) Niacin-tryptophan relationships for evaluating niacin equivalents. Am J Clin Nutr 34: 423–427.PubMedGoogle Scholar
  13. Karthikeyan K, Thappa DM (2002) Pellagra and skin. Int J Dermatol 41: 476–481.PubMedCrossRefGoogle Scholar
  14. Kleta R, Romeo E, Ristic Z, et al (2004) Mutations in SLC6A19, encoding B°AT1, cause Hartnup disorder. Nat Genet 36: 999–1002.PubMedCrossRefGoogle Scholar
  15. Komrower GM, Westall R (1967) Hydroxykynureninuria. Am J Dis Child 113: 77–80.PubMedGoogle Scholar
  16. Komrower GM, Wilson V, Clamp JR, Westall RG (1964) Hydroxykynureninuria. Arch Dis Child 39: 250–256.PubMedGoogle Scholar
  17. Martin JR, Mellor CS, Fraser FC (1995) Familial hypertryptophanemia in two siblings. Clin Genet 47: 180–183.PubMedCrossRefGoogle Scholar
  18. Nielsen EG, Vedsø, S, Zimmermann-Nielsen C (1966) Hartnup disease in three siblings. Dan Med Bul 13: 155–161.Google Scholar
  19. Oakley A, Wallace J (1994) Hartnup disease presenting in an adult. Clin Exp Dermatol 19: 407–408.PubMedCrossRefGoogle Scholar
  20. Pawlak D, Tankiewicz A, Matys T, Buczko W (2003) Peripheral distribution of kynurenine metabolites and activity of kynurenine pathway enzymes in renal failure. J Physiol Pharmacol 54: 175–189.PubMedGoogle Scholar
  21. Peters JC (1991) Trytophan nutrition and metabolism: an overview. In: Schwarcz R, Young SN, Brown RR, eds. Kynurenine and Serotonin Pathways. Adv Exp Med Biol 294: 345–358.PubMedGoogle Scholar
  22. Podskarbi T, Kohlmetz T, Gathof BS, et al (1996) Molecular characterization of Duarte-1 and Duarte-2 variants of galactose-1-phosphate uridyltransferase. J Inherit Metab Dis 19: 638–644.PubMedCrossRefGoogle Scholar
  23. Reddi OS, Reddy MVR, Reddy KRS (1978) Familial hydroxykynureninuria. Hum Hered 28: 238–240.PubMedGoogle Scholar
  24. Salih MAM, Bender DA, McCreanor GM (1985) Lethal familial pellagra-like skin lesion associated with neurologic and developmental impairment and the development of cataracts. Pediatrics 76: 787–793.PubMedGoogle Scholar
  25. Scriver CR, Mahon B, Levy HL, et al (1987) The Hartnup phenotype: Mendelian transport disorder, multifactorial disease. Am J Hum Genet 40: 401–412.PubMedGoogle Scholar
  26. Shin YS, Koch HG, Köhler M (1998) Duarte-1 (Los Angeles) and Duarte-2 (Duarte) variants in Germany: two new mutations in the GALT gene which cause a GALT activity decrease by 40–50 of normal red cells. J Inheitr Metab Dis 21: 232–235.CrossRefGoogle Scholar
  27. Snedden W, Mellor CS, Martin JR (1983) Familial hypertryptophanemia, tryptophanuria and indoleketonuria. Clin Chim Acta 131: 247–256.PubMedCrossRefGoogle Scholar
  28. Stone TW, Darlington LG (2002) Endogenous kynurenines as targets for drug discovery and development. Nature Rev 1: 609–620.CrossRefGoogle Scholar
  29. Toma S, Nakamura M, Tone S, et al (1997) Cloning and recombinant expression of rat and human kynureninase. FEBS Lett 408: 5–10.PubMedCrossRefGoogle Scholar
  30. Ubbink JB, Vermaak WJH, Bissbort SH (1991) High-performance liquid chromatographic assay of human lymphocyte kynureninase activity levels. J Chromatogr 566: 369–375.PubMedCrossRefGoogle Scholar
  31. Wardlaw GM, Insel PM (1996) Water Soluble Vitamins—Perspectives in Nutrition, 3rd edn. St Louis: Mosby, 438–477.Google Scholar
  32. Wilcken B, Yu JS, Brown DA (1977) Natural history of Hartnup disease. Arch Dis Child 52: 38–40.PubMedCrossRefGoogle Scholar

Copyright information

© SSIEM and Springer 2007

Authors and Affiliations

  • M. Christensen
    • 1
  • M. Duno
    • 1
  • A. M. Lund
    • 1
  • F. Skovby
    • 1
  • E. Christensen
    • 1
  1. 1.Department of Clinical GeneticsRigshospitalet 4062CopenhagenDenmark

Personalised recommendations